A study for the effect of ulinastatin for suppression of hyperamylasemia and hyperlipasemia induced by peroral double-balloon enteroscopy
Not Applicable
- Conditions
- Patients who undergo peroral double-balloon enteroscopy
- Registration Number
- JPRN-UMIN000000679
- Lead Sponsor
- Intmed3 DBE study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients who have acute pancreatitis or chronic pancreatitis (2) patients with known hypersensitivity to ulinastatin (3) women who are pregnant or possible pregnant (4) patients taking endoscopy which is not aiming the insertion of endoscope deep into the small intestine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method serum pancreatic amylase level and serum lipase level 3 hours after and in the next morning of peroral double-balloon enteroscopy
- Secondary Outcome Measures
Name Time Method presence or absence of pancreatitis after peroral double-balloon enteroscopy